NCT03906539View on ClinicalTrials.gov

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 22, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Dyslipidemias
Interventions
DRUG

Atorvastatin 10mg

Atorvastatin 10 mg per day

DIETARY_SUPPLEMENT

Virgin Coconut Oil (VCO)

Capsule VCO (1000 mg/day)

OTHER

Placebo

Placebo capsule - 1 capsule per day

Trial Locations (1)

751019

AIIMS, Bhubaneswar, Bhubaneshwar

All Listed Sponsors
collaborator

Coconut Development Board, Government of India

UNKNOWN

lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT03906539 - Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia | Biotech Hunter | Biotech Hunter